University of Hawaii, John A. Burns School of Medicine, Honolulu, HI, USA.
NOVA Southeastern University, Kiran Patel College of Allopathic Medicine, Fort Lauderdale, FL, USA.
Injury. 2024 Mar;55(3):111361. doi: 10.1016/j.injury.2024.111361. Epub 2024 Jan 17.
This narrative review aims to evaluate the efficacy of adjunct direct peritoneal resuscitation (DPR) in the treatment of adult damage control surgery (DCS) patients both with and without hemorrhagic shock, and its impact on associated outcomes.
PubMed, Google Scholar, EMBASE, ProQuest, and Cochrane were searched for relevant articles published through April 13th, 2023. Studies assessing the utilization of DPR in adult DCS patients were included. Outcomes included time to abdominal closure, intra-abdominal complications, in-hospital mortality, and ICU length of stay (ICU LOS).
Five studies evaluating 437 patients were included. In patients with hemorrhagic shock, DPR was associated with reduced time to abdominal closure (DPR 4.1 days, control 5.9 days, p = 0.002), intra-abdominal complications including abscess formation (DPR 27 %, control 47 %, p = 0.04), and ICU LOS (DPR 8 days, control 11 days, p = 0.004). Findings in patients without hemorrhagic shock were conflicting. Closure times were decreased in one study (DPR 5.9 days, control 7.7 days, p < 0.02) and increased in another study (DPR 3.5 days, control 2.5 days, p = 0.02), intra-abdominal complications were decreased in one study (DPR 27 %, control 47 %, p = 0.04) and similar in another, and ICU LOS was decreased in one study (DPR 17 days, control 24 days, p < 0.002) and increased in another (DPR 13 days, control 11.4 days, p = 0.807).
In patients with hemorrhagic shock, adjunct DPR is associated with reduced time to abdominal closure, intra-abdominal complications such as abscesses, fistula, bleeding, anastomotic leak, and ICU LOS. Utilization of DPR in patients without hemorrhagic shock showed promising but inconsistent findings.
本叙事综述旨在评估辅助直接腹膜复苏(DPR)在治疗伴有和不伴有出血性休克的成人损伤控制性手术(DCS)患者中的疗效,及其对相关结局的影响。
检索了 PubMed、Google Scholar、EMBASE、ProQuest 和 Cochrane 数据库,以获取截至 2023 年 4 月 13 日发表的相关文章。纳入评估成人 DCS 患者中 DPR 应用的研究。结局包括腹部关闭时间、腹腔内并发症、院内死亡率和 ICU 住院时间(ICU LOS)。
纳入了 5 项评估 437 例患者的研究。在伴有出血性休克的患者中,DPR 与腹部关闭时间的缩短相关(DPR 为 4.1 天,对照组为 5.9 天,p=0.002),腹腔内并发症包括脓肿形成(DPR 为 27%,对照组为 47%,p=0.04)和 ICU LOS(DPR 为 8 天,对照组为 11 天,p=0.004)。在不伴有出血性休克的患者中,结果存在矛盾。一项研究中,DPR 组的关闭时间缩短(DPR 为 5.9 天,对照组为 7.7 天,p<0.02),另一项研究中则延长(DPR 为 3.5 天,对照组为 2.5 天,p=0.02),一项研究中 DPR 组的腹腔内并发症减少(DPR 为 27%,对照组为 47%,p=0.04),另一项研究中则相似,一项研究中 ICU LOS 缩短(DPR 为 17 天,对照组为 24 天,p<0.002),另一项研究中则延长(DPR 为 13 天,对照组为 11.4 天,p=0.807)。
在伴有出血性休克的患者中,辅助 DPR 与腹部关闭时间的缩短、脓肿、瘘管、出血、吻合口漏和 ICU LOS 等腹腔内并发症相关。在不伴有出血性休克的患者中,DPR 的应用显示出有希望但不一致的结果。